Reversed-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their active metabolites

Reversed-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their active metabolites

The chromatographic behaviour of some ACE inhibitors and their active metabolites was examined under conditions of reversed-phase thin-layer chromatography on RP-18 silica using water-methanol, water-ethanol and water-acetone as binary solvent systems. The relationship between the R M values and the...

Full description

Bibliographic Details
Main Authors:	Odović Jadranka, Stojimirović Biljana, Aleksić Mirjana, Milojković-Opsenica Dušanka, Tešić Živoslav
Format:	Article
Language:	English
Published:	Serbian Chemical Society 2006-01-01
Series:	Journal of the Serbian Chemical Society
Subjects:	ace inhibitors reversed-phase thin-layer chromatography lipophilicity
Online Access:	http://www.doiserbia.nb.rs/img/doi/0352-5139/2006/0352-51390606621O.pdf

Similar Items

Reversed-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their active metabolites
by: JADRANKA ODOVIC, et al.
Published: (2006-06-01)

Normal-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their metabolites
by: Odović Jadranka, et al.
Published: (2009-01-01)

Normal-phase thin-layer chromatography of some angiotensin converting enzyme (ACE) inhibitors and their metabolites
by: JADRANKA ODOVIĆ, et al.
Published: (2009-06-01)

Evaluation of ACE inhibitors lipophilicity using in silico and chromatographically obtained hydrophobicity parameters
by: Odović Jadranka V., et al.
Published: (2013-01-01)

ELIMINATION OF ANGIOTENSIN – CONVERTING ENZIME INHIBITORS BY PERITONEAL DIALISATE
by: Jadranka Odović, et al.
Published: (2011-06-01)

CORRELATION BETWEEN ANGIOTENSIN-CONVERTING ENZYME INHIBITORS LIPOPHILICITY AND PROTEIN BINDING DATA
by: Jasna Trbojević-Stanković, et al.
Published: (2012-01-01)

Thin-layer chromatography of several antihypertensive drugs from the group of angiotensin converting enzyme inhibitors
by: Aleksić Mirjana B., et al.
Published: (2001-01-01)

Thin-layer chromatography of several antihypertensive drugs from the group of angiotensin converting enzyme inhibitors
by: ZIVOSLAV LJ. TESIC, et al.
Published: (2001-01-01)

The Evaluation of Angiotensin-Converting Enzyme Inhibitors in Renal Elimination with Selected Molecular Descriptors
by: Trbojevic Jovana, et al.
Published: (2017-06-01)

Chromatography methods in investigation of lipophilicity of the biological active substances
by: Odović Jadranka V., et al.
Published: (2009-01-01)

Quantitative structure-toxicity relationship study of some natural and synthetic coumarins using retention parameters
by: Rabtti El Hadi M.A., et al.
Published: (2012-01-01)

ROLE OF ANGIOTENSIN CONVERTING ENZYMES ACE AND ACE2 IN DIABETES INDUCED CARDIOVASCULAR DYSFUNCTION
by: Kanakamedala, Keerthy
Published: (2007)

The influence of certain molecular descriptors of fecal elimination of angiotensin II receptor antagonists
by: Trbojević-Stanković Jasna B., et al.
Published: (2015-01-01)

Determination of lipophilicity for antitumor acridinone derivatives supported by gradient high-performance liquid chromatography method
by: Koba Marcin, et al.
Published: (2012-02-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting
by: Shilpa Tejpal, et al.
Published: (2020-02-01)

The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
by: Craig Steven McLachlan
Published: (2020-07-01)

Relationship between the bioavailability and molecular properties of angiotensin II receptor antagonists
by: Trbojević Jovana B., et al.
Published: (2016-01-01)

The effect of the molecular properties of calcium channel blockers on their elimination route
by: Trbojević-Stanković Jasna B., et al.
Published: (2015-01-01)

ROLE OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) IN OBESITY-ASSOCIATED HYPERTENSION
by: Gupte, Manisha
Published: (2011)

Impact of Diabetes on ACE/ACE2 Balance and Angiotensin II Type 1 Receptor Expression in db/db Diabetic Mice
by: Madhu, Malav Navinchandra
Published: (2009)

Investigation of the Mechanism and Effect of Enalapril, Angiotensin-Converting Enzyme (ACE) Inhibitor, on Proliferation, Apoptosis, and Migration in Colorectal Cancer Cells
by: Asma Mostafapour, et al.
Published: (2020-08-01)

Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
by: Perna Annalisa, et al.
Published: (2005-10-01)

Study of angiotensin converting enzyme (ACE) inhibitory effects of main Papaver spp. alkaloids
by: SA Ziai, et al.
Published: (2004-02-01)

Angiotensin-I Converting Enzyme (ACE) Inhibitory and Anti-Oxidant Activities of Sea Cucumber (Actinopyga lecanora) Hydrolysates
by: Raheleh Ghanbari, et al.
Published: (2015-12-01)

The Role of Angiotensin Converting Enzyme (ACE) 2 in a Murine Model of Insulin Resistance and Albuminuria
by: Weir, Nathan Michael
Published: (2012)

Genetic Variability Associated with Angiotensin Converting Enzyme (ACE) Gene Polymorphism in Sportsmen Pursuing Different Sports
by: Paulauskas Algimantas, et al.
Published: (2009-01-01)

Angiotensin Converting Enzyme (ACE) Inhibitory Activity of Crude and Fractionated Snakehead Fish (Channa striata) Fillet Extract
by: Setyani Budiari, et al.
Published: (2018-08-01)

Production and purification of glucosamine and angiotensin-I converting enzyme (ACE) inhibitory peptides from mushroom hydrolysates
by: Pin Zhang, et al.
Published: (2017-09-01)

Identification of three novel angiotensin-converting enzyme inhibitory peptides derived from cauliflower by-products by multidimensional liquid chromatography and bioinformatics
by: Riccardo Zenezini Chiozzi, et al.
Published: (2016-12-01)

Estimation of angiotensin-converting enzyme inhibitors protein binding degree using chromatographic hydrophobicity data
by: Trbojević-Stanković Jasna, et al.
Published: (2015-01-01)

Purification and characterization of angiotensin converting enzyme-inhibitory peptides derived from Stichopus horrens: Stability study against the ACE and inhibition kinetics
by: Bita Forghani, et al.
Published: (2016-01-01)

Effect of hyperglycemia and thiazolidinediones on cardiac angiotensin converting enzyme 2 (ACE2) and neprilysin (NEP) in db/db diabetic mice.
by: Fadnavis, Rucha
Published: (2017)

The angiotensin converting enzyme (ace) gene polymorphism: Insight study of the renal regulation of the arterial blood pressure
by: Durmić Tijana, et al.
Published: (2016-01-01)

The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection
by: Ahmed O. Kaseb, et al.
Published: (2021-03-01)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01)

NO ASSOCIATION BETWEEN ANGIOTENSIN I CONVERTING ENZYME (ACE) I/D POLYMORPHISM AND GASTRIC CANCER RISK AMONG JAPANESE
by: HAMAJIMA, NOBUYUKI, et al.
Published: (2011)

Effect of dietary supplementation of ginger and turmeric rhizomes on angiotensin-1 converting enzyme (ACE) and arginase activities in L-NAME induced hypertensive rats
by: Ayodele Jacob Akinyemi, et al.
Published: (2015-08-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)